Article | April 23, 2021

Aseptic Environmental Monitoring For Vaccine Manufacturing

By Patrick Hutchins and Mike Dingle

Vaccine Manufacturing Vials Getty Images-1292355769

Regulatory requirements do not change regardless of the scale of the operation. However, if scale up includes distribution to additional geographical regions, additional or different requirements may need to be met. In the United States (US) market, you must follow the Food and Drug Administration (FDA) Aseptic Processing Guide. Most other markets are guided by the harmonized Annex 1 of the European Union (EU), Pharmaceutical Inspection Co-operation Scheme (PIC/S), and World Health Organization (WHO) Good Manufacturing Practices (GMPs).

To meet immediate vaccine demand, aseptic manufacturing capacity must increase quickly. This means environmental monitoring programs must adapt rapidly as well. Thoughtful planning can help.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online